Could you please clarify who exactly owns BMS? Is it a publicly traded company, a private entity, or perhaps a consortium of investors? Are there any major shareholders or stakeholders that have a significant influence on the company's operations and decision-making processes? Additionally, is there any information available regarding the ownership structure and the history of BMS's ownership? Understanding the ownership of BMS is crucial in assessing its credibility, stability, and potential for growth in the cryptocurrency and finance industry.
7 answers
CoinMaster
Mon Sep 02 2024
State Street Global Advisors, Inc. rounds out the top three shareholders, with a 4.2% stake in the company. This investment underscores the trust that State Street places in Bristol-Myers Squibb's ability to deliver value to its shareholders.
charlotte_bailey_doctor
Mon Sep 02 2024
Bristol-Myers Squibb, a prominent pharmaceutical company, does not have hedge funds as its primary owners. Instead, the company's ownership structure reveals a diverse array of institutional investors.
lucas_taylor_teacher
Mon Sep 02 2024
Among these investors, The Vanguard Group, Inc. stands out as the largest shareholder, holding a significant 9.0% of the company's outstanding shares. This position underscores Vanguard's confidence in Bristol-Myers Squibb's long-term prospects.
HallyuHero
Mon Sep 02 2024
Following closely behind Vanguard is BlackRock, Inc., another prominent asset manager, which holds 7.8% of the company's shares outstanding. BlackRock's investment in Bristol-Myers Squibb reflects its assessment of the company's financial health and growth potential.
Carlo
Sun Sep 01 2024
The diversity of shareholders in Bristol-Myers Squibb highlights the company's appeal to a wide range of investors, from large institutional players to individual investors. This mix of ownership helps to ensure that the company's interests are aligned with those of its shareholders.